PLXP PLx Pharma Inc.

PLx Pharma Inc is a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard delivery system to provide safer and more effective aspirin products.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  03/13/2014
Outstanding shares:  27,539,229
Average volume:  173,182
Market cap:   $61,963,265
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYYCCS1
Valuation   (See tab for details)
PE ratio:   -2.32
PB ratio:   1.88
PS ratio:   6.02
Return on equity:   -174.71%
Net income %:   -440.87%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy